As a target for miR-101A, overexpression of FOS can lead to aggravated myocardial fibrosis after MI (Pan et al., 2012), and inhibition of Fos/AP-1 can reduce inflammatory response and cardiac dysfunction (Zhuang et al., 2022). This evidence concerns the gene JUN and myocardial infarction.